Skip to main content

Advertisement

SpringerLink
Log in

Preanalytical Interferences Compromise the Clinical Validity of Matrix Metalloproteinase 1 as Marker of Colorectal Cancer

  • Colorectal Cancer
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Tahara K, Mimori K, Iinuma H, et al. Serum matrix-metalloproteinase-1 is a bona fide prognostic marker for colorectal cancer. Ann Surg Oncol. 2010;17:3362–9.

    Article  PubMed  Google Scholar 

  2. Hurst NG, Stocken DD, Wilson S, et al. Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients. Br J Cancer. 2007;97:971–7.

    Article  PubMed  CAS  Google Scholar 

  3. Jung K, Wu CW. Methodological weakness in using correlation coefficients for assessing the interchangeability of analyte data between samples collected under different sampling conditions—the example of matrix metalloproteinase 9 determined in serum and plasma samples. Clin Chem Lab Med. 2010;48:733–6.

    Article  PubMed  CAS  Google Scholar 

  4. Jung K. Is serum matrix metalloproteinase 9 a useful biomarker in detection of colorectal cancer? Considering pre-analytical interference that may influence diagnostic accuracy. Br J Cancer. 2008;99:553–4.

    Article  PubMed  CAS  Google Scholar 

  5. Jung K, Klotzek S, Stephan C, Mannello F, Lein M. Impact of blood sampling on the circulating matrix metalloproteinases 1, 2, 3, 7, 8, and 9. Clin Chem. 2008;54:772–4.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University Hospital Charité, Berlin, Germany

    Klaus Jung

  2. Berlin Institute for Urologic Research, Berlin, Germany

    Klaus Jung

Authors
  1. Klaus Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Klaus Jung.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jung, K. Preanalytical Interferences Compromise the Clinical Validity of Matrix Metalloproteinase 1 as Marker of Colorectal Cancer. Ann Surg Oncol 18 (Suppl 3), 231–232 (2011). https://doi.org/10.1245/s10434-010-1495-0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-1495-0

Keywords

Search

Navigation